Cargando…
Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study
The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profilin...
Autores principales: | Au, Lewis, Boos, Laura Amanda, Swerdlow, Anthony, Byrne, Fiona, Shepherd, Scott T.C., Fendler, Annika, Turajlic, Samra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470737/ https://www.ncbi.nlm.nih.gov/pubmed/32979319 http://dx.doi.org/10.1016/j.cell.2020.09.005 |
Ejemplares similares
-
1557O Adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients: The CAPTURE study
por: Shepherd, S.T.C., et al.
Publicado: (2021) -
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022) -
Understanding Omicron: Transmissibility, immune evasion and antiviral intervention
por: Hoffmann, Markus, et al.
Publicado: (2022) -
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
por: Fendler, Annika, et al.
Publicado: (2021) -
Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection
por: Flynn, Michael, et al.
Publicado: (2018)